From trials to practice: Immune checkpoint inhibitor therapy for melanoma patients in Norway.

Authors: Costa, Denise Reis^1,2 b.k.andreassen@kreftregisteret.no, Winge-Main, Anna K.^3,4, Skog, Anna⁵, Tsuruda, Kaitlyn M.¹, Robsahm, Trude Eid¹, Andreassen, Bettina Kulle¹

Source: Acta Oncologica. 2024, Vol. 63 Issue 1, p965-973. 9p.

Subject Terms: *THERAPEUTIC use of antineoplastic agents, *MELANOMA, *RESEARCH funding, *INCOME, *CLINICAL trials, *SOCIOECONOMIC factors, *TREATMENT effectiveness, *CANCER patients, *REPORTING of diseases, *AGE distribution, *IMMUNE checkpoint inhibitors, *METASTASIS, *LONGITUDINAL method, *PROGRAMMED cell death 1 receptors, *SOCIODEMOGRAPHIC factors, *COMPARATIVE studies, *NIVOLUMAB, *DISEASE incidence, *EDUCATIONAL attainment, *EVALUATION

Geographic Terms: NORWAY

Melanom - utredning og primærbehandling

Authors: Berentzen, Åshild, Brevig, Trine, Hermann, Robert, Ryder, Truls, Winge-Main, Anna K.

Source: Tidsskrift for Den norske lægeforening. 142(15):1314-1317

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN630365087&indx=1&recIds=ETOCRN630365087

T cell receptor therapy against melanoma—Immunotherapy for the future?

Authors: Winge‐Main, Anna K.^1,2 (AUTHOR), Wälchli, Sébastien¹ (AUTHOR), Inderberg, Else Marit¹ (AUTHOR) elsin@rr-research.no

Source: Scandinavian Journal of Immunology. Oct2020, Vol. 92 Issue 4, p1-20. 20p.

Subject Terms: *T cell receptors, *IMMUNE checkpoint inhibitors, *CELLULAR therapy, *IMMUNOTHERAPY

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Silent, isolated ACTH deficiency in malignant melanoma patients treated with immune checkpoint inhibitors.

Authors: Heck, Ansgar, Winge-Main, Anna K.

Source: BMJ Case Reports; Jul2021, Vol. 14 Issue 7, p1-4, 4p

Clinical Effectiveness of an At-Home Auditory Training Program: A Randomized Controlled Trial.

Authors: Humes, Larry E., Skinner, Kimberly G., Kinney, Dana L., Rogers, Sara E., Main, Anna K., Quigle, Tera M., Quigley, Tera M

Source: Ear & Hearing (01960202); Sep/Oct2019, Vol. 40 Issue 5, p1043-1060, 18p

The Effectiveness of Hearing Aids and Two Service-Delivery Models in Older Adults: A Randomized Double-Blind, Placebo-Controlled Clinical Trial: A comparison of audiology best-practice services versus an OTC delivery model.

Authors: HUMES, LARRY E., HERRING, CHRISTINE, KINNEY, DANA L., MAIN, ANNA K., QUIGLEY, TERA M., ROGERS, SARA E.

Source: Hearing Review; May2017, Vol. 24 Issue 5, p12-19, 6p

Subject Terms: TREATMENT of hearing disorders, HEARING aids, MEDICAL care, MEDICAL protocols, HEALTH outcome assessment, RANDOMIZED controlled trials, BLIND experiment, OLD age, ECONOMICS